By 
Elon Musk’s brain-computer interface startup, Neuralink, has closed a $650 million Series E funding round. The company announced the news in a blog post, revealing investors such as ARK Invest, Founders Fund, Sequoia Capital, and Thrive Capital, among others.
This latest funding round comes after Neuralink’s significant progress in its brain chip technology.
The company has:
– Conducted human clinical trials, implanting brain chips in five individuals with severe paralysis
– Received breakthrough device designation from the U.S. Food and Drug Administration (FDA), accelerating development and review processes
The deal values Neuralink at around $9 billion pre-money, according to Semafor. This marks a significant increase from its previous funding rounds, including a $280 million Series D funding round in 2023, with an additional $43 million tranche added later.
With this substantial funding, Neuralink is poised to further develop its brain-computer interface technology, potentially revolutionizing the treatment of paralysis and other neurological conditions. As the company continues to push the boundaries of innovation, its future prospects look promising.
Comments